Contacto y Bibliografía
Nariyuki, I., Shunzo, H., Kiyoshi, T. (1984) Biosynthesis of gallic and ellagic acids
with 14C-labeled compounds inAcer and Rhus leaves. The Botanical
Magazine. 97(3); 355-367.
Fan, L., Dong, M., Lan, X., Yu, N., Wei, W., Lu, J., Li, J. (2003) Pharmacokinetic srudy of ellagic acid in rat after oral administration of promgranate leaf extract. Journal of Chromatography B. 796; 189-194. Quideau, S. (2009) Chemistry and Biology of Ellagitannins: An Undereastimated Class of Bioactive Plant. World Scientific. United Kingdom. Vishal, R., Subhash, L., Mohan, V., Prasad, A. (2010) Subacute toxicity of ellagic acid in colesterol fed hyperlipidemic rats. Toxicology International. 15(2); 91-95. Tasaki, M., Umemura, T., Maeda, M., Ishii, Y., Olamura, T., Inoue, Y., Kuroiwa, Y., Hirose, M., Nishikawa, A. (2008) Safety assessment of ellagic acid, a food aditive, in a subchronic toxicity study using F344 rats. PubMed. 46(3); 1119-24. Lesca, P. (1983) Protective effects of ellagic acid and other plants phenols on venzo[a]pyrene-induced neoplasia in mice. PubMed. 4(12); 1651-3 Lee, W., Ou, H., Hsu, W., Shou, M., Tseng, J., Hsu, S., Tsai, K., Sheu, W. (2010) Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endotelial cells. Journal of Vascular Surgery. 52(5); 1290-1300. Syed, U., Ganapasam, S. (2010) Differential Inhibitory Effects of the Polyphenol Ellagic Acido n Infñammatory Mediators NF-kB, iNOS, COX-2, TNF-α, and IL-6 in 1,2-Dimethylhydrazine-Induced Rat Colon Carcinogenesis. Pharmacological Society. 197(2). Leelavinothan, P., Ramasamy, S. (2010) Effect of ellagic acido n cyclosporine A-induced oxidative famage in the liver of rats. Fundamental & Clinical Pharmacology. 22(4); 395-401. Atessahín, A., Ceribast, A., Yuce, A., Bulmus, O., Cikim, G. (2006) Role of Ellagic Acid againd Cisplatin-Induced Nephrotoxiity and Oxidative Stress in Rats. Norfic Pharmacological Society. 100(2); 121-126. Devipriya, N., Sudheer, A., Menon, V. (2007) Dose-response effect of ellagic acido n circulatory antioxidants and lipids during alcohol-induced toxicity in experimental rats. Fundamental & Clinical Pharmacology. 21(6); 621-630. Stoner, G., Wang, L., Casto, B. (2008) Laboratory and clinical studies of cáncer chemoprevention by antioxidants in berries. Oxford Journals. 29(9); 1665-1674. Stoner, G., Sardo, C., Apseloff, G., Mullet, D., Wargo, W., Pound, V., Singh, A., Sanders, J., Aziz, R., Casto, B., Sun, X. (2005) Pharmacokinetics of Anthocyanins and Ellagic Acid in Healthy Colunteers Fed Freeze-Dried Black Raspberries Daily for 7 Days. The Journal of Clinical Pharmacology. 45(10); 1153-1164. Falsaperla, M., Morgia, G., Tartarone, A., Ardito, R., Romano, G. (2005) Support Ellagic Acid Therapy in Patients with Hormone Refractory Prostate Cancer (HRPC) on Standard Chemotherapy Using Vinorelbine and Estramustine Phosphate. ELSEVIER. 47(4); 449-455. Alkayali, Ahmad, Lake Forest, CA 92630. Ellagic acid food supplement prepared from promegrante seed. Europa. (EP 1 721 532 B1; US 125596). 27 Julio 2006. Appl. 06003982.3. 10 p. |
|